Iron Status and Risk of Heart Disease, Stroke, and Diabetes: A Mendelian Randomization Study in European Adults.

Yunan Liu Robert J Clarke Derrick A Bennett Geng Zong Wei Gan

Published in: Journal of the American Heart Association (2024)

Higher levels of iron biomarkers were protective for CAD, had adverse effects on T2D, but had no effects on IS or HF. Randomized trials are now required to assess effects of iron supplements on risk of CAD in high-risk older people.

Keyphrases

coronary artery disease
iron deficiency
type diabetes
cardiovascular disease
atrial fibrillation
pulmonary hypertension
emergency department
glycemic control
metabolic syndrome
weight loss
adverse drug
subarachnoid hemorrhage